A Brief Overview on Corona Virus Disease-2019 (COVID-19): Epidemiology and Severity | Chapter 3 | Current Innovations in Disease and Health Research Vol. 3

 This branch describe the Epidemiology, Severity of COVID-19 and Practice Points from an Indian Perspective.With the establishment and spread of the 2019 novel corona virus (2019-nCoV) or the harsh acute respiring syndrome halo virus 2 (SARS-CoV-2), skilled is a new public health disaster that warns the entire experience. In December 2019, the virus spread from sock to humans by way of unidentified intermediary variety in Wuhan, Hubei Province, China.  The disease is sent by inhalation or trade infected droplets and the readiness period ranges from 2 to 14 d. active treatment forSARS-CoV-2 is deficient; however, two tests investigating the clinical efficiency of remdesivir are underway in China. Currently, productive infection control mediation is the only way to prevent the spread of SARS- CoV-2.

Author(s) Details:

Disha Chouhan ,
Department of Pharmaceutical Chemistry, School of Pharmaceutical Science and Research, Balaghat, Madhya Pradesh, India.

Rajesh Mujariya,
Department of Pharmaceutics, School of Pharmaceutical Science and Research, Balaghat, Madhya Pradesh, India.

Please see the link here: https://stm.bookpi.org/CIDHR-V3/article/view/11349